Recently, artificial pancreas (AP) systems are emerging and they use machine-learning algorithms to reduce the frequency of hypoglycemic episodes, even in the presence of intensive insulin treatment, and are among the greatest advances in diabetes care in recent development [7, 8]. The gene discussed is INS; the disease is diabetes mellitus.